poster, student poster, clinical vignette student poster, clinical vignette poster, and innovation...

Download POSTER, STUDENT POSTER, CLINICAL VIGNETTE STUDENT POSTER, CLINICAL VIGNETTE POSTER, AND INNOVATION ACADEMY…

Post on 26-Jun-2018

215 views

Category:

Documents

2 download

Embed Size (px)

TRANSCRIPT

  • POSTER, STUDENT POSTER, CLINICAL VIGNETTE POSTER, AND INNOVATION ACADEMY POSTER

    PRESENTATION INSTRUCTIONS

    POSTER Viewing: Thursday, April 16 and Friday, April 17 Location: Coles Ballroom (PEI Convention Centre) Viewing Times Thursday April 16:

    Morning break 11:00 am to 12:30 pm o STUDENT POSTER PRESENTERS (SP) MUST

    BE AT THEIR POSTERS TO ANSWERS QUESTIONS!

    Lunch between 12:30 pm to 1:00 pm Welcome Reception 6:30 pm to 8:30 pm

    Viewing Times Friday April 17: Morning break 11:00 am to 12:30 pm

    o POSTER (P), CLINICAL VIGNETTE (CV), AND INNOVATION ACADEMY (IA) POSTER PRESENTERS MUST BE AT THEIR POSTERS TO ANSWERS QUESTIONS!

    Lunch between 12:30 pm to 1:00 pm Poster Set-Up Time:

    Wednesday April 15 between 4:00 pm 6:00 pm Thursday April 16 between 7:00 am 10:00 am

    Poster Removal Time:

    Friday April 17 at 1:00 pm * Should you require assistance onsite, please go to the Registration Desk. GENERAL INFORMATION

    Poster Boards are 4ft high x 8ft wide. A good poster size is 3ft high x 6ft wide. Velcro (male side) and pin friendly.

    All presenting authors MUST be registered for the annual conference, no later than Monday March 2, 2015. If registration is not complete by this date, the abstract will be REMOVED and will NOT be published.

    STUDENT POSTER Presenters must fill in and submit to (communications@ammi.ca) a Student/Technologist/Trainee Awards Competition Form by Monday March 2, 2015. http://ammi.ca/media/75949/Student-Technologist-Trainee%20Award%20Form%20-%20EN%20v2.pdf HOTEL AND CONFERENCE REGISTRATION INFORMATION The Hotel Room Blocks are full at both the Delta Prince Edward and Holman Grand. Please contact Stephanie Wolkowycki at the AMMI Canada Secretariat at info@ammi.ca to make arrangements. REGISTRATION Register now: http://ammi.emsreg.com/ammi15/public/splash1.aspx

    mailto:communications@ammi.cahttp://ammi.ca/media/75949/Student-Technologist-Trainee%20Award%20Form%20-%20EN%20v2.pdfhttp://ammi.ca/media/75949/Student-Technologist-Trainee%20Award%20Form%20-%20EN%20v2.pdfmailto:info@ammi.cahttp://ammi.emsreg.com/ammi15/public/splash1.aspx

  • STUDENT POSTER PRESENTATION ASSIGNMENT LIST

    Serial No. Prog. No. Initial Last name Title

    0003 SP01 Bahareh Ghadaki COPD Symptom and Disease Screening in an HIV Population 0004 SP02 Withdrawn

    0007 SP03 Gabriel Chan Characterization of Canadian Hospital Infection Control Practices for Caregivers and Visitors

    0021 SP04 Chris Lata Antimicrobial Prescribing Practices in the Treatment of Suspected UTI in the Elderly in the Emergency Department: a Retrospective Single Centre Study

    0026 SP05 Hong Yuan Zhou The Infectiousness and/or Virulence of Isoniazid-Resistant vs. Susceptible Pulmonary Tuberculosis: A Case-Control Study in Alberta

    0028 SP06 Ramzi Fattouh Meropenem MIC Profile of Carbapenemase-Producing Enterobacteriaceae in a Low Prevalence Region

    0031 SP07 Nipunie Rajapakse Creation of A Novel Pediatric Antimicrobial Stewardship Advanced Fellowship Training Program

    0035 SP08 Roshan Priyantha Emerging Antimicrobial Resistance among Staphylococcus Pseudintermedius, a Potential Zoonoses of Canine Origin

    0036 SP09 Anthony Bai Positive Impact of Infectious Disease Consultation on Quality of Care, Mortality and Length of Stay in Staphylococcus aureus Bacteremia: Results from a Large Multicenter Cohort Study

    0040 SP10 Carla Penney Prospective Observational Study of Diagnosis of Urinary Tract Infection and Response to Therapy in Long Term Care

    0045 SP11 Jasmine Chong Molecular Epidemiology of Vancomycin Heteroresistant Coagulase-Negative Staphylococci in a Neonatal Intensive Care Unit in Quebec

    0046 SP12 Sylvain Lother Increasing Incidence of Group C and Group G Streptococcal Bacteremia Attributed to Increased Bacterial Virulence Factors and Poor Outcomes

    0047 SP13 Manal Rostom Antimicrobial Stewardship in Primary Care: An Evaluation of the Management of Acute Uncomplicated Cystitis in a Family Health Team

    0048 SP14 Withdrawn 0049 SP15 Mohammad Alghounaim Clostridium difficile Infections (CDI) in Children: Are we

    overestimating rates just because of the diagnostic method used?

    0051 SP16 Sumana Fathima Surveillance of Human Parainfluenza Types 1-4 and Association with Acute Lower Respiratory Tract Infections in Hospitalized Cases, Alberta, Canada (2010 2013)

    0052 SP17 Nathan Zelyas Clostridium difficile infection in solid organ transplant recipients at a tertiary care centre during 2006-2013

    0056 SP18 Constantina Boikos Safety of the Live-Attenuated Intranasal Influenza Virus (LAIV) Vaccine in Children and Adolescents with Cystic Fibrosis and their Healthy Siblings

  • Revised April 7, 2015 Page 2 of 6

    Serial No. Prog. No. Initial Last name Title 0058 SP19 Jianbo Zhang Severe Skin Lesions Induced by a Predominant CA-MRSA Strain

    USA300 are Associated with a Unique Neutrophil Response and Involvement of Proteinase Activated Receptors (PARs)

    0060 SP20 lise Fortin Surveillance of Antimicrobial Use in Qubec Acute Care Hospitals: A Dream or Almost Reality?

    0065 SP21 Kristin Y. Popiel Usefulness of Fecal Calprotectin and Serum Procalcitonin in Predicting a Positive C. difficile Toxin Gene Polymerase Chain Reaction Assay

    0066 SP22 Diana Whellams Successful use of intrathecal colistin in a case of Pseudomonas aeruginosa ventriculitis: a case report and brief review of the literature

    0068 SP23 Geoffrey Shumilak Prevalence of Anemia in the Saskatchewan Population with HIV Infection

    0073 SP24 Yan Chen Rapid Identification of Bacteria in Positive Blood Cultures Using Smudge Plate Preparation and MALDI-TOF MS System

    0077 SP25 Chris Le Assessment of the management of suspected urinary tract infections for identification of targeted antimicrobial stewardship interventions

    0078 SP26 Lauren Goodliffe Clinical Features and Outcomes of Influenza Infection in Community Dwelling Older Adults Presenting to Six Urban Emergency Departments

    0080 SP27 Derek R. MacFadden Engaging Infectious Diseases And Microbiology Residents in Improving the Value of Healthcare: Choosing Wisely

    0082 SP28 Luke Ryan Incidence and Outcomes of Hospital-acquired C. difficile Infection at a Large Community Hospital Before and After a Multipronged Prevention and Management Initiative

    0084 SP29 Andrew Denisuik The Continued Rise of Extended-Spectrum -Lactamase-Producing Escherichia coli in Canadian Hospitals: CANWARD 2007-2013

    0085 SP30 Samuel De Ltoile-Morel

    Inpatient Care of Community Acquired Pneumonia: Opportunities for Improvement

    0086 SP31 Yannick Emond Feasibility of UV-C light disinfection in a Canadian hospital. 0089 SP32 Sneha Suresh Non-Polio Enterovirus Types Associated with Acute Flaccid

    Paralysis A Systematic Review 0090 SP33 Shazia Masud Evaluation of Matrix Assisted Laser Desorption Ionization-Time

    of Flight Mass Spectrometry (MALDI-TOF MS) for Yeast Identification

    0091 SP34 Erika Koeck Xpert MTB/RIF as a Supplemental Test to Acid-Fast Bacilli Sputum Microscopy in the Diagnosis of Tuberculosis: Potential Resource Savings

    0092 SP35 Alexandra Mcfarlane Hospitalized Influenza Patients during 2013-2014; a Comparison of ICU and Ward Treated Patients including Antimicrobial Therapy, Adverse Events, and Outcomes

    0094 SP36 Galit Pomeranz Clinical Spectrum of Rhinovirus Infections in Hospitalized Children in Israel - a single center's experience

    0098 SP37 David Harris Prosthetic Joint Infections: Patterns of Practice for Diagnosis, Management, and Outcome

  • Revised April 7, 2015 Page 3 of 6

    Serial No. Prog. No. Initial Last name Title 0100 SP38 Emilie Vallieres Urinary Biomarkers in Patients with Cystic Fibrosis 0101 SP39 Amy Delorme Carbon Source Modulates Paradoxical Growth Effect of

    Caspofungin in Candida albicans 0103 SP40 Hilal Al Sidairi Cost-effectiveness of MALDI-TOF MS in Clinical Analysis of Urine

    Specimens in Nova Scotia 0150 SP41 Claudia Martinez de

    la Pea Role of Type IV Pili in the Clostridium difficile Pathogenic Program

    0121 SP42 Byron Berenger Detection and Characterization of a 2014 Escherichia coli O157:H7 Outbreak in Alberta by Multiple Molecular Methods Including Whole Genome Sequencing

    0125 SP43 Angela Ma Heat Resistant Shiga Toxin-Producing Escherichia coli (STEC) from Clinical Cases in Alberta

    0127 SP44 Dahn Jeong The Use of Antibiotics in the Treatment of Skin and Soft Tissue Infections in Selected First Nations Communities

    0131 SP45 Alexander Lawandi The Role of Inter-Hospital Sample Transport in Total Assay Time for Microbiological Screening Tests

    0137 SP46 Cindy Lam Investigation of Matrix Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for detection of Clostridium difficile toxin A and B from stool samples

    0139 SP47 Aaron Campigotto Cumulative antimicrobial susceptibility data from ICUs at one institution: should data be combined?

    0144 SP48 Gauri Shah Infectious Complications After Central Venous Catheter Repair in Pediatric Patients

    0145 SP49 William J. Connors Acute Odontogenic Infection Management in the OPAT Clinic Setting: a Quality Improvement Study in Calgary, Alberta

  • Revised April 7, 2015 Page 4 of 6

    POSTER PRESENTATION ASSIGNMENT LIST Serial No.

    Prog. No.

    Initial Last name Title

    0005 P01 Nawal Al Musayeib Antiprotozoal potential of phenolic compounds from Kleinia odora

    0006 P02 Adrian Shephard In-vitro Antiviral Action of Amylmetacresol (AMC) and 2,4-Dichlorobenzyl Alcohol (BCDA) Against the Respiratory Pathogen Parainfluenza Type 3